NASDAQ: TLSITrisalus Life Sciences Inc Stock Ownership - Who owns Trisalus Life Sciences?
Insider buying vs selling
Have Trisalus Life Sciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mats Wahlstrom | Director | 2026-05-15 | 60,000 | $2.53 | $151.80kBuy |
| Gary B. Gordon | Director | 2026-05-15 | 10,000 | $2.46 | $24.60kBuy |
| Richard Marshak | Chief Commercial Officer | 2026-05-15 | 543 | $2.67 | $1.45kSell |
| David Patience | Chief Financial Officer | 2026-05-15 | 7,100 | $2.43 | $17.25kBuy |
| Michael P. Stansky | Director | 2026-05-15 | 410,000 | $2.50 | $1.03MBuy |
| Michael P. Stansky | Director | 2026-05-15 | 200,000 | $2.50 | $500.00kBuy |
| Mary T. Szela | CEO and President | 2026-05-15 | 39,682 | $2.59 | $102.78kBuy |
| Mary T. Szela | CEO and President | 2026-03-17 | 15,944 | $3.85 | $61.38kSell |
| Richard Marshak | Chief Commercial Officer | 2026-03-16 | 419 | $4.12 | $1.73kSell |
| Jennifer Stevens | Chief Regulatory Officer | 2026-03-16 | 774 | $4.12 | $3.19kSell |
TLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TLSI insiders and whales buy or sell their stock.
TLSI Shareholders
What type of owners hold Trisalus Life Sciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Equity Ab Frankenius | 11.38% | 6,989,748 | $33.06M | Insider |
| Medtech Acquisition Sponsor LLC | 10.18% | 6,249,999 | $29.56M | Insider |
| First Light Asset Management LLC | 8.25% | 5,066,827 | $23.97M | Institution |
| Mats Wahlstrom | 4.82% | 2,962,030 | $14.01M | Insider |
| Kerry R. Hicks | 3.77% | 2,317,400 | $10.96M | Insider |
| Awm Investment Company Inc | 3.39% | 2,079,105 | $9.83M | Institution |
| Nantahala Capital Management LLC | 3.37% | 2,070,827 | $9.80M | Institution |
| Michael P. Stansky | 3.00% | 1,840,118 | $8.70M | Insider |
| Blackrock Inc | 2.44% | 1,499,547 | $7.09M | Institution |
| Wasatch Advisors LP | 2.34% | 1,437,960 | $6.80M | Institution |
TLSI vs Medical Device Stocks
Trisalus Life Sciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.